A federal judge has recommended an end to the consolidation and centralization of Zicam lawsuits, which began nearly two years ago after federal regulators forced the removal of Zicam nasal sprays and gels from the market due to a risk that users may experience permanent loss of smell.…
The U.S. Supreme Court has indicated that a stock fraud lawsuit can move forward against the makers of the cold remedy Zicam, whom investors say misrepresented their company’s growth potential by hiding the fact that some users were reporting problems with loss of their sense of smell from Zicam. …
A Zicam class action lawsuit has made its way to the U.S. Supreme Court, where the justices will try to determine how much information companies are obligated to share with investors about consumer complaints associated with their products. …
The makers of Zicam have indicated that they are offering a $15.5 million to settle lawsuits brought by consumers who allege that they lost their sense of taste and smell due to the company’s recalled line of nasal sprays and gels. …
A $429,000 settlement has been reached between the makers of Zicam allergy and cold medicines and several California counties over allegations that the company was attempting to mislead consumers with their packaging. …
A settlement has been reached by Matrixx Initiatives to resolve Zicam lawsuits filed by a group of plaintiffs who alleged that the company misrepresented the safety of their nasal sprays and gels, which federal regulators have indicated may cause people to lose their sense of smell. The company continues to face hundreds of Zicam injury lawsuits filed on behalf of consumers who have actually suffered loss of smell after using the cold remedy.…
A University of California researcher says that the findings of a new study provide proof that zinc-based Zicam nasal products, which were recalled last year, may cause some people to lose their sense of smell. …
A Zicam class action lawsuit filed by shareholders will be brought before the Supreme Court by Matrixx Initiatives, who claims it did not need to share reports with shareholders about loss of smell with Zicam, which eventually led to a recall of some variations of the cold remedy. …
The FDA is refusing to reverse a warning about loss of smell from Zicam, which led to a recall last summer for the over-the-counter cold remedy’s nasal sprays and gels.…
Researchers conducting a study of dietary supplements say that a lack of regulation is resulting in potentially poisonous products being sold to consumers in the United States unchecked. …
